Figures & data
Figure 1 Flow diagram showing patient recruitment and follow-up.
![Figure 1 Flow diagram showing patient recruitment and follow-up.](/cms/asset/940dda95-322f-46fe-8d38-d012cbfd7e9f/dppa_a_12178367_f0001_c.jpg)
Table 1 Baseline Demographic and Clinical Characteristics of Study Population
Table 2 Comparison of Outcome Parameters (Adherence and Clinical Outcomes) Among Groups
Figure 2 Comparison of adverse drug events observed between groups (UC vs PC).
![Figure 2 Comparison of adverse drug events observed between groups (UC vs PC).](/cms/asset/04935990-ae5f-4d10-b3e1-80ddd4b7b8f0/dppa_a_12178367_f0002_c.jpg)
Table 3 Drug–drug Interactions Between HCV DAAs and Concomitant Drugs
Table 4 Summary of EQ5D-3L Data for Health Related Quality of Life Domains